Search Results 5821-5830 of 42282 for oral

  1. Oral Cavity & Pharynx. County. 65.6%. Ovary. 0.0. Colorectal. Pancreas. 0.0. 0.0. Adults aged 50-75 years who reported. State. Stomach. 0.0. 0.0. Thyroid. 0.0.

  2. Oral Cavity & Pharynx. 8.4. 0.0. Esophagus. 8.1. 5.7. County. 65.2%. Liver & Bile Duct. 7.7. 5.4. Colorectal. Brain & ONS. 7.4. 0.0. Adults aged 50-75 years who ...

  3. Oral Cavity & Pharynx. 1.7. 2.1. Target. 76.6%. 74.4%. Uncategorized. 0.0. 0.0. Data Sources: Incidence and Mortality from State Cancer Profiles (for FL, AZ, WI ...

  4. Oral Cavity & Pharynx. 20.6 reported Mammogram in 2 years. Bladder. 15.1. 0.0. Leukemia. 12.5. 0.0. Target. 80.5%. Pancreas. Brain & ONS. Cervix. Esophagus.

  5. Oral Cavity & Pharynx. 8.0. 2.8. Adults aged 50-75 years who reported. State. Cervix. 5.9. 0.0. Esophagus. 5.2. 6.6 being up-to-date with colorectal cancer ...

  6. Pediatrics Clinical Trials - Medical Professionals

    The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD (cases) as ...

  7. Topotecan (intravenous route) - Side effects & uses - Mayo Clinic

    Also, avoid persons who have taken oral polio vaccine within the past several months. Do not get close to them and do not stay in the same room with them ...

  8. Ramucirumab (intravenous route) - Side effects & uses - Mayo Clinic

    Ramucirumab injection is also together with erlotinib used as first-line treatment for metastatic (cancer that has already spread) non-small cell lung cancer ( ...

  9. Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia - Mayo Clinic

    Oral etoposide (up to 200 mg orally per day) may be given as an alternative ... Antileukemic therapy for the treatment of AML (excluding hydroxyurea or oral ...

  10. Atrial Fibrillation Ablation Clinical Trials - Mayo Clinic Research

    The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral ...